Associations of IL-1β and IL-6 gene polymorphisms with Parkinson's disease

被引:19
作者
Li, N. [1 ]
Wang, J-X [1 ]
Huo, T-T [1 ]
Zhao, J-R [1 ]
Wang, T. J. [1 ]
机构
[1] Hebei Gen Hosp, Dept Neurol, Shijiazhuang, Hebei, Peoples R China
关键词
IL-1; beta; IL-6; Gene polymorphism; Parkinson's disease; LONG-TERM; SUSCEPTIBILITY; CYTOKINES; RISK;
D O I
10.26355/eurrev_202101_24657
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The aim of this study was to explore the associations of interleukin-1 beta (IL-1 beta) and IL-6 gene polymorphisms with the pathogenesis of Parkinson's disease. PATIENTS AND METHODS: A total of 200 patients with Parkinson's disease in our hospital were collected as the disease group. Meanwhile, 200 healthy subjects were taken as the control group. Peripheral blood samples were drawn from all research subjects. The polymorphic regions of IL-1 beta and IL-6 were amplified via polymerase chain reaction (PCR). Moreover, the polymorphisms were detected and analyzed, followed by further analysis based on the changes in gene expressions and Hoehn-Yahr grade of patients. RESULTS: The allele distributions at IL-1 beta rs571556428 (p=0.015) and IL-6 rs543214973 (p=0.012) were statistically different between control group and disease group. In disease group, the G allele frequency at 1L-1 beta rs571556428 and T allele frequency at IL-6 rs543214973 were significantly higher (p<0.05). Genotype distributions at IL-1 beta rs572292175 (p=0.017) and rs571556428 (p=0.000), and IL-6 rs543214973 (p=0.002) in disease group were also different from those in control group. In addition. the frequencies of CT genotype at IL-1 beta rs572292175, AA genotype at IL-1 beta rs571556428 and AA genotype at IL-6 rs543214973 in disease group were significantly lower (p<0.05). After modeling and analysis, it was found that the distribution of recessive model at IL-1 beta rs571556428 (p=0.012) and IL-6 rs543214973 (p=0.014) in disease group exhibited significant differences from those in control group. The frequencies of TA haplotype at IL-1 beta rs572292175 and rs571556428 (p=0.038) and GA haplotype at IL-6 rs1474348 and rs543214973 (p=0.047) in disease group were lower than those in control group (p<0.05). The polymorphisms at IL-1 beta rs571556428 and IL-6 rs1474348 were significantly associated with gene expression (p<0.05). Moreover, the expressions of IL-1 beta and IL-6 rose significantly in patients with GG genotype at rs571556428 and CG genotype at rs1474348. respectively (p<0.05). Furthermore. the polymorphism at IL-1 beta rs571556428 was significantly correlated with the grade of Parkinson's disease (p=0.000). Parkinson's disease was in a higher grade (grade 4-5) in patients with AA genotype. whereas in a lower grade (grade 1-2) in patients with GG and AG genotypes. CONCLUSIONS: IL-1 beta and IL-6 gene polymorphisms are significantly associated with the pathogenesis of Parkinson's disease.
引用
收藏
页码:890 / 897
页数:8
相关论文
共 21 条
[11]   Association of the rs1611115 polymorphism in DBH gene with Parkinson's disease: a meta-analysis [J].
Kang, Shan ;
Bi, Mingxia ;
Du, Xixun ;
Jiao, Qian ;
Jiang, Hong .
NEUROLOGICAL SCIENCES, 2018, 39 (12) :2085-2089
[12]   Parkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort [J].
Lawton, Michael ;
Baig, Fahd ;
Rolinski, Michal ;
Ruffman, Claudio ;
Nithi, Kannan ;
May, Margaret T. ;
Ben-Shlomo, Yoav ;
Hu, Michele T. M. .
JOURNAL OF PARKINSONS DISEASE, 2015, 5 (02) :269-279
[13]   Genetic polymorphism rs3760396 of the chemokine (C-C motif) ligand 2 gene (CCL2) associated with the susceptibility of lung cancer in a pathological subtype-specific manner in Han-ancestry Chinese: a case control study [J].
Li, Xu ;
Lin, Fangcai ;
Zhou, Hong .
BMC CANCER, 2016, 16
[14]   200 Years of Parkinson's disease: what have we learnt from James Parkinson? [J].
McDonald, Claire ;
Gordon, Gavin ;
Hand, Annette ;
Walker, Richard W. ;
Fisher, James M. .
AGE AND AGEING, 2018, 47 (02) :209-214
[15]   Validation of an Ambulatory Capacity Measure in Parkinson Disease: A Construct Derived from the Unified Parkinson's Disease Rating Scale [J].
Parashos, Sotirios A. ;
Elm, Jordan ;
Boyd, James T. ;
Chou, Kelvin L. ;
Dai, Lin ;
Mari, Zoltan ;
Morgan, John C. ;
Sudarsky, Lewis ;
Wielinski, Catherine L. .
JOURNAL OF PARKINSONS DISEASE, 2015, 5 (01) :67-73
[16]   Cytokines and cytokine networks target neurons to modulate long-term potentiation [J].
Prieto, G. Aleph ;
Cotman, Carl W. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 34 :27-33
[17]   Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease A Systematic Review and Meta-analysis [J].
Qin, Xiao-Yan ;
Zhang, Shu-Ping ;
Cao, Chang ;
Loh, Y. Peng ;
Cheng, Yong .
JAMA NEUROLOGY, 2016, 73 (11) :1316-1324
[18]   Assessing the validity of proxy caregiver reporting for potential palliative care outcome measures in Parkinson's disease [J].
Sebring, Kelly ;
Shattuck, Jo ;
Berk, Julie ;
Boersma, Isabel ;
Sillau, Stefan ;
Kluger, Benzi M. .
PALLIATIVE MEDICINE, 2018, 32 (09) :1522-1528
[19]   Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1 [J].
Wills, Anne-Marie A. ;
Perez, Adriana ;
Wang, Jue ;
Su, Xiao ;
Morgan, John ;
Rajan, Suja S. ;
Leehey, Maureen A. ;
Pontone, Gregory M. ;
Chou, Kelvin L. ;
Umeh, Chizoba ;
Mari, Zoltan ;
Boyd, James .
JAMA NEUROLOGY, 2016, 73 (03) :321-328
[20]   Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis [J].
Yousefi, Azizollah ;
Najafi, Mehri ;
Motamed, Farzaneh ;
Mahmoudi, Elham ;
Bidoki, Alireza Zare ;
Sadr, Maryam ;
Rahman, Farzaneh ;
Farhmand, Fatemeh ;
Khodadad, Ahmad ;
Fallahi, Gholamhossein ;
Rezaei, Nima .
ANNALS OF HEPATOLOGY, 2018, 17 (06) :1021-1025